[Federal Register Volume 59, Number 176 (Tuesday, September 13, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22597]


[[Page Unknown]]

[Federal Register: September 13, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
[GN# 2268]

 

National Vaccine Advisory Committee (NVAC), Subcommittee on 
Future Vaccines, Public Meeting

AGENCY: Office of the Assistant Secretary for Health, HHS.

SUMMARY: The Department of Health and Human Services (DHHS) and the 
Office of the Assistant Secretary for Health (OASH) are announcing the 
forthcoming meeting of the Future Vaccines Subcommittee of the National 
Vaccine Advisory Committee.

DATES: Date, Time and Place: September 27, at 1 p.m. to 5 p.m., Hubert 
H. Humphrey Building, Room 703A, 200 Independence Avenue, S.W., 
Washington, D.C. 20201. The entire meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Written requests to participate should 
be sent to Chester A. Robinson, D.P.A., Acting Executive Secretary, 
National Vaccine Advisory Committee, National Vaccine Program Office, 
5600 Fishers Lane, Rockwall II Building, Suite 1075, Rockville, MD 
20857, (303) 594-2277.
    Agenda: Open Public Hearing: Interested persons may formally 
present data, information, or views orally or in writing on issues to 
be discussed by the Subcommittee. Those desiring to make such 
presentations should make a request to the contact person before 
September 19, and submit a brief description of the information they 
wish to present to the Subcommittee. Requests should include the names 
and addresses of proposed participants. A maximum of 10 minutes will be 
allowed for a given presentation, but the time may be adjusted 
depending on the number of persons presenting. Any person attending the 
meeting who does not request an opportunity to speak in advance of the 
meeting will be allowed to make an oral presentation at the conclusion 
of the meeting, if time permits, at the Chairperson's discretion.
    Open Subcommittee Discussion: The Subcommittee will discuss (1) 
priority topics to be addressed in FY 1995, and (2) ways of ensuring 
that new vaccine candidates can be made available for efficacy trials 
(Phase III), including assessment of private sector capacity to produce 
pilot lots. Meetings of the Subcommittee shall be conducted, insofar as 
is practical, in accordance with a more detailed agenda distributed at 
the beginning of the meeting. Persons interested in specific agenda 
items may ascertain from the contact person the approxumate time of 
discussion. A list of subcommittee members and the charter of the NVAC 
Committee will be available at the meeting. Those unable to attend the 
meeting may request this information from the contact person.

    Dated: August 31, 1994.
Jeannette R. DeLawter,
Committee Management Specialist.
[FR Doc. 94-22597 Filed 9-12-94; 8:45 am]
BILLING CODE 4160-17-M